Due to the ability of esculeoside A to improve the impaired glucose tolerance in treated db/db mice, we speculated that it is partly accountable for the treatment type 2 diabetes by improving the sensitivity of muscles or fat to insulin, thereby increasing their glucose uptake. The gene discussed is INS; the disease is type 2 diabetes mellitus.